Dr. Jennifer M. Levine
Claim this profileNYP/Weill Cornell Medical Center
Expert in Langerhans Cell Histiocytosis
Expert in Brain Tumor
14 reported clinical trials
32 drugs studied
Area of expertise
1Langerhans Cell Histiocytosis
Global LeaderStage I
Stage II
MTOR positive
2Brain Tumor
Global LeaderStage I
Stage II
MTOR positive
Affiliated Hospitals
Clinical Trials Jennifer M. Levine is currently running
Genetic Testing-Directed Therapy
for Pediatric Cancer
This Pediatric MATCH screening and multi-sub-study phase II trial studies how well treatment that is directed by genetic testing works in pediatric patients with solid tumors, non-Hodgkin lymphomas, or histiocytic disorders that have progressed following at least one line of standard systemic therapy and/or for which no standard treatment exists that has been shown to prolong survival. Genetic tests look at the unique genetic material (genes) of patients' tumor cells. Patients with genetic changes or abnormalities (mutations) may benefit more from treatment which targets their tumor's particular genetic mutation, and may help doctors plan better treatment for patients with solid tumors or non-Hodgkin lymphomas.
Recruiting1 award Phase 214 criteria
Ensartinib
for Cancer
This phase II Pediatric MATCH treatment trial studies how well ensartinib works in treating patients with solid tumors, non-Hodgkin lymphoma, or histiocytic disorders with ALK or ROS1 genomic alterations that have come back (recurrent) or does not respond to treatment (refractory) and may have spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body (advanced). Ensartinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.
Recruiting1 award Phase 217 criteria
More about Jennifer M. Levine
Clinical Trial Related7 years of experience running clinical trials · Led 14 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Jennifer M. Levine has experience with
- Erdafitinib
- Olaparib
- Palbociclib
- Selpercatinib
- Tipifarnib
- Vemurafenib
Breakdown of trials Jennifer M. Levine has run
Langerhans Cell Histiocytosis
Brain Tumor
Lymphoma
Tumors
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Jennifer M. Levine specialize in?
Jennifer M. Levine focuses on Langerhans Cell Histiocytosis and Brain Tumor. In particular, much of their work with Langerhans Cell Histiocytosis has involved Stage I patients, or patients who are Stage II.
Is Jennifer M. Levine currently recruiting for clinical trials?
Yes, Jennifer M. Levine is currently recruiting for 2 clinical trials in New York New York. If you're interested in participating, you should apply.
Are there any treatments that Jennifer M. Levine has studied deeply?
Yes, Jennifer M. Levine has studied treatments such as Erdafitinib, Olaparib, Palbociclib.
What is the best way to schedule an appointment with Jennifer M. Levine?
Apply for one of the trials that Jennifer M. Levine is conducting.
What is the office address of Jennifer M. Levine?
The office of Jennifer M. Levine is located at: NYP/Weill Cornell Medical Center, New York, New York 10065 United States. This is the address for their practice at the NYP/Weill Cornell Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.